ArticleJAC-antimicrobial resistance2024
Experience with expanded use of oritavancin in a tertiary hospital: indications, tolerability and outcomes.
Thilinie Dulanjalee Bandaranayake et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it